Cargando…
Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406258/ https://www.ncbi.nlm.nih.gov/pubmed/36008840 http://dx.doi.org/10.1186/s12931-022-02127-1 |
| _version_ | 1784774076824289280 |
|---|---|
| author | Yang, Jin Ma, Libing Guo, Li Zhang, Ting Leng, Zhiwei Jia, Mengmeng Chen, Fangyuan Qi, Weiran Zhang, Xingxing Wang, Qing Yang, Yuan Feng, Luzhao Ren, Lili Yang, Weizhong Wang, Chen |
| author_facet | Yang, Jin Ma, Libing Guo, Li Zhang, Ting Leng, Zhiwei Jia, Mengmeng Chen, Fangyuan Qi, Weiran Zhang, Xingxing Wang, Qing Yang, Yuan Feng, Luzhao Ren, Lili Yang, Weizhong Wang, Chen |
| author_sort | Yang, Jin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9406258 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94062582022-08-26 Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan Yang, Jin Ma, Libing Guo, Li Zhang, Ting Leng, Zhiwei Jia, Mengmeng Chen, Fangyuan Qi, Weiran Zhang, Xingxing Wang, Qing Yang, Yuan Feng, Luzhao Ren, Lili Yang, Weizhong Wang, Chen Respir Res Correction BioMed Central 2022-08-25 2022 /pmc/articles/PMC9406258/ /pubmed/36008840 http://dx.doi.org/10.1186/s12931-022-02127-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Yang, Jin Ma, Libing Guo, Li Zhang, Ting Leng, Zhiwei Jia, Mengmeng Chen, Fangyuan Qi, Weiran Zhang, Xingxing Wang, Qing Yang, Yuan Feng, Luzhao Ren, Lili Yang, Weizhong Wang, Chen Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan |
| title | Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan |
| title_full | Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan |
| title_fullStr | Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan |
| title_full_unstemmed | Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan |
| title_short | Correction to: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan |
| title_sort | correction to: seroprevalence and dynamics of anti-sars-cov-2 antibodies: a longitudinal study based on patients with underlying diseases in wuhan |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406258/ https://www.ncbi.nlm.nih.gov/pubmed/36008840 http://dx.doi.org/10.1186/s12931-022-02127-1 |
| work_keys_str_mv | AT yangjin correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT malibing correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT guoli correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT zhangting correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT lengzhiwei correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT jiamengmeng correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT chenfangyuan correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT qiweiran correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT zhangxingxing correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT wangqing correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT yangyuan correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT fengluzhao correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT renlili correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT yangweizhong correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan AT wangchen correctiontoseroprevalenceanddynamicsofantisarscov2antibodiesalongitudinalstudybasedonpatientswithunderlyingdiseasesinwuhan |